Jérôme Langrand
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Jérôme Langrand has a total of 206 co-authors. Here are the top co-authors by number of shared publications:
- Dominique Vodovar
Centre Antipoison de Paris, Hôpital Fernand Widal - Assistance Publique des Hôpitaux de Paris
18 shared publications - Magali Labadie
Nouvelle Aquitaine Poison Control Centre, University Hospital Center of Bordeaux, Bordeaux
17 shared publications Nathalie Paret
Lyon Poison Control Center, Hospices Civils de Lyon (HCL) Lyon France
14 shared publicationsEmmanuel Puskarczyk
East PCC
12 shared publicationsAudrey Nardon
Bordeaux PCC
11 shared publicationsHervé Laborde-Casterot
Centre Antipoison de Paris, Hôpital Fernand Widal – Assistance Publique des Hôpitaux de Paris
11 shared publications
Latest Publications
- Open Access
- 13 August 2026
- Published by Wiley in Plants, People, Planet
Accidental plant poisonings in France: Lessons from a decade of national toxicovigilance
Social Impact Statement: Accidental plant poisonings reveal how modern societies are losing everyday botanical knowledge once central to food and health safety. By analyzing a decade of French toxicovigilance data, this study shows that most severe cases arise from plant misidentification or misguided self‐medication. These findings highlight the urgent need to reconnect people with plants through education, cultural transmission, and collaboration between health professionals and botanists. Preserving ethnobotanical knowledge is not only vital for preventing poisonings but also for sustaining safe, respectful, and informed relationships between humans, biodiversity, and the living environments we share. Summary: Accidental plant poisonings in France illustrate changing relationships between people and plants. Severe cases mainly result from confusion with wild edible species or therapeutic misuse, revealing both the persistence of traditional practices and the erosion of vernacular botanical knowledge. This study aimed to describe the epidemiological, clinical, and botanical characteristics of accidental plant exposures reported to French Poison Control Centres (PCCs) over a 10‐year period and to identify the main taxa, exposure contexts and populations at risk. A retrospective descriptive analysis was conducted using the French national database of poisoning cases (2012–2021). Cases were classified by plant category, family, and group. Clinical severity was graded according to the Poisoning Severity Score (PSS), and causality assessed using the French toxicovigilance method. Among 82,819 accidental plant exposures, 29% were symptomatic. Most involved ornamental (53%) or wild plants (23%). Children under 6 years represented 69% of cases but were rarely symptomatic. Adults were more often affected by moderate to severe poisonings (0.7%), mainly linked to food confusions ( Colchicum autumnale and Oenanthe crocata ) or self‐medication ( Digitalis purpurea and Cascabela thevetia ). Exposures peaked in spring and summer, reflecting seasonal plant availability and human outdoor activity. Accidental plant poisonings are frequent yet usually mild. Severe cases remain preventable and highlight the need for targeted education and culturally sensitive prevention strategies combining toxicovigilance, botanical expertise, and preservation of ethnobotanical knowledge.
- 13 August 2026
- Published by Wiley in Plants, People, Planet
Open AccessAccidental plant poisonings in France: Lessons from a decade of national toxicovigilance
Social Impact Statement: Accidental plant poisonings reveal how modern societies are losing everyday botanical knowledge once central to food and health safety. By analyzing a decade of French toxicovigilance data, this study shows that most severe cases arise from plant misidentification or misguided self‐medication. These findings highlight the urgent need to reconnect people with plants through education, cultural transmission, and collaboration between health professionals and botanists. Preserving ethnobotanical knowledge is not only vital for preventing poisonings but also for sustaining safe, respectful, and informed relationships between humans, biodiversity, and the living environments we share. Summary: Accidental plant poisonings in France illustrate changing relationships between people and plants. Severe cases mainly result from confusion with wild edible species or therapeutic misuse, revealing both the persistence of traditional practices and the erosion of vernacular botanical knowledge. This study aimed to describe the epidemiological, clinical, and botanical characteristics of accidental plant exposures reported to French Poison Control Centres (PCCs) over a 10‐year period and to identify the main taxa, exposure contexts and populations at risk. A retrospective descriptive analysis was conducted using the French national database of poisoning cases (2012–2021). Cases were classified by plant category, family, and group. Clinical severity was graded according to the Poisoning Severity Score (PSS), and causality assessed using the French toxicovigilance method. Among 82,819 accidental plant exposures, 29% were symptomatic. Most involved ornamental (53%) or wild plants (23%). Children under 6 years represented 69% of cases but were rarely symptomatic. Adults were more often affected by moderate to severe poisonings (0.7%), mainly linked to food confusions ( Colchicum autumnale and Oenanthe crocata ) or self‐medication ( Digitalis purpurea and Cascabela thevetia ). Exposures peaked in spring and summer, reflecting seasonal plant availability and human outdoor activity. Accidental plant poisonings are frequent yet usually mild. Severe cases remain preventable and highlight the need for targeted education and culturally sensitive prevention strategies combining toxicovigilance, botanical expertise, and preservation of ethnobotanical knowledge.
- 13 April 2026
- Published by Taylor & Francis in Clinical Toxicology
- Vol. 64 (9) , 1-5
Intentional xylazine poisoning: a nationwide French poison control center study
Xylazine, an α2-adrenergic agonist used as a veterinary sedative, has emerged as an adulterant of illicit opioids, contributing to fatal overdoses in North America and has recently been detected in Europe. In France, despite alarmist media reports, data on xylazine exposures are scarce. We retrospectively reviewed intentional xylazine exposures reported to the eight French poison control centers from January 2010 to December 2024. Cases were extracted from the French National Database of Poisonings. Inclusion required intentional use; severity was assessed using the Poison Severity Score. Nineteen intentional exposures were identified: seventeen in the context of a suicide attempt, one homicidal, and one recreational. Mean age was 36.4 years; sex ratio 2.6 (male/female). For the cases occurring in the context of a suicide attempt, eleven involved xylazine alone, and six in combination with other drugs (mainly ketamine or fentanyl). Three fatalities occurred (16%), and six patients developed severe clinical features (Poisoning Severity Score 3), including coma, bradycardia, and hypotension. The single recreational case involved a fentanyl/xylazine mixture with full recovery. Over a 14-year period, intentional xylazine poisonings reported to French Poison Control Centers were uncommon, mainly occurring in the context of a suicide attempt, and often linked to occupational access to veterinary sedatives. These data do not support community or recreational spread. Nonetheless, observed cases confirm xylazine's life-threatening potential. This retrospective analysis highlights the rarity of reported xylazine exposures in French poison centre data, strengthened toxicological surveillance and coordination between Poison Control Center and drug-checking networks are needed to detect any shift toward broader use and guide prevention efforts.
- 13 April 2026
- Published by Taylor & Francis in Clinical Toxicology
- Vol. 64 (9) , 1-5
Intentional xylazine poisoning: a nationwide French poison control center study
Xylazine, an α2-adrenergic agonist used as a veterinary sedative, has emerged as an adulterant of illicit opioids, contributing to fatal overdoses in North America and has recently been detected in Europe. In France, despite alarmist media reports, data on xylazine exposures are scarce. We retrospectively reviewed intentional xylazine exposures reported to the eight French poison control centers from January 2010 to December 2024. Cases were extracted from the French National Database of Poisonings. Inclusion required intentional use; severity was assessed using the Poison Severity Score. Nineteen intentional exposures were identified: seventeen in the context of a suicide attempt, one homicidal, and one recreational. Mean age was 36.4 years; sex ratio 2.6 (male/female). For the cases occurring in the context of a suicide attempt, eleven involved xylazine alone, and six in combination with other drugs (mainly ketamine or fentanyl). Three fatalities occurred (16%), and six patients developed severe clinical features (Poisoning Severity Score 3), including coma, bradycardia, and hypotension. The single recreational case involved a fentanyl/xylazine mixture with full recovery. Over a 14-year period, intentional xylazine poisonings reported to French Poison Control Centers were uncommon, mainly occurring in the context of a suicide attempt, and often linked to occupational access to veterinary sedatives. These data do not support community or recreational spread. Nonetheless, observed cases confirm xylazine's life-threatening potential. This retrospective analysis highlights the rarity of reported xylazine exposures in French poison centre data, strengthened toxicological surveillance and coordination between Poison Control Center and drug-checking networks are needed to detect any shift toward broader use and guide prevention efforts.
- 17 February 2026
- Published by Taylor & Francis in Clinical Toxicology
- Vol. 64 (6) , 497-502
Clinical toxicity of daridorexant: a retrospective analysis of poison centre data
Daridorexant is a dual orexin receptor antagonist approved for insomnia treatment. While clinical trials suggest a favourable safety profile, real-world data on acute toxicity and overdose are scarce. This study aimed to characterize the clinical presentation, severity, and outcomes of daridorexant exposures reported to French National Poison Centre network, focusing on co-ingested substances and sex-specific differences. A retrospective review of all daridorexant-related cases reported between March 2024 and May 2025 was conducted. Demographic, clinical, and toxicological data were extracted and classified using standardized criteria. Poisoning severity was graded with Poisoning Severity Score. Ordinal logistic regression assessed the association between co-intoxication and Poisoning Severity Score. Fifty-one cases were identified (70.6% female, age range eight months-89 years): 30 were suicide attempts, seven therapeutic errors, five adverse drug reactions, and three pediatric unintentional ingestions. Seventeen mono-intoxications presented mainly with somnolence (n = 7), vertigo (n = 1), and nausea (n = 1). Median ingested dose was 200 mg (IQR 100-362.5 mg). Co-intoxications occurred primarily with benzodiazepines, antidepressants, analgesics, antidiabetics, neuroleptics, or alcohol, producing symptoms such as somnolence, confusion, hallucinations, tachycardia, hypoglycaemia, and in severe cases coma (lowest Glasgow Coma Scale was seven). Regression analysis showed that co-intoxication was significantly associated with increased severity in females (β = 1.95, SE = 0.74, P = 0.0086), whereas no significant effect was observed in males. Severe outcomes occurred exclusively in cases with co-intoxications, particularly among women. Daridorexant overdoses were generally of low severity, with no fatalities. Most patients recovered with supportive care. Co-intoxication may increase toxicity, particularly in females, but findings should be interpreted cautiously due to small subgroups. While daridorexant appears safe when taken alone, clinicians should remain vigilant in polypharmacy scenarios involving central nervous system depressants. Further studies are needed to confirm sex-related differences and refine risk stratification in overdose management.
- 17 February 2026
- Published by Taylor & Francis in Clinical Toxicology
- Vol. 64 (6) , 497-502
Clinical toxicity of daridorexant: a retrospective analysis of poison centre data
Daridorexant is a dual orexin receptor antagonist approved for insomnia treatment. While clinical trials suggest a favourable safety profile, real-world data on acute toxicity and overdose are scarce. This study aimed to characterize the clinical presentation, severity, and outcomes of daridorexant exposures reported to French National Poison Centre network, focusing on co-ingested substances and sex-specific differences. A retrospective review of all daridorexant-related cases reported between March 2024 and May 2025 was conducted. Demographic, clinical, and toxicological data were extracted and classified using standardized criteria. Poisoning severity was graded with Poisoning Severity Score. Ordinal logistic regression assessed the association between co-intoxication and Poisoning Severity Score. Fifty-one cases were identified (70.6% female, age range eight months-89 years): 30 were suicide attempts, seven therapeutic errors, five adverse drug reactions, and three pediatric unintentional ingestions. Seventeen mono-intoxications presented mainly with somnolence (n = 7), vertigo (n = 1), and nausea (n = 1). Median ingested dose was 200 mg (IQR 100-362.5 mg). Co-intoxications occurred primarily with benzodiazepines, antidepressants, analgesics, antidiabetics, neuroleptics, or alcohol, producing symptoms such as somnolence, confusion, hallucinations, tachycardia, hypoglycaemia, and in severe cases coma (lowest Glasgow Coma Scale was seven). Regression analysis showed that co-intoxication was significantly associated with increased severity in females (β = 1.95, SE = 0.74, P = 0.0086), whereas no significant effect was observed in males. Severe outcomes occurred exclusively in cases with co-intoxications, particularly among women. Daridorexant overdoses were generally of low severity, with no fatalities. Most patients recovered with supportive care. Co-intoxication may increase toxicity, particularly in females, but findings should be interpreted cautiously due to small subgroups. While daridorexant appears safe when taken alone, clinicians should remain vigilant in polypharmacy scenarios involving central nervous system depressants. Further studies are needed to confirm sex-related differences and refine risk stratification in overdose management.
- 20 January 2026
- Published by Taylor & Francis in Clinical Toxicology
- p. 1-8
Tropatepine poisoning and management: a series of 458 cases
Tropatepine is an antiparkinsonian drug that can be associated with antimuscarinic delirium in overdose. Two acetylcholinesterase inhibitors, neostigmine and physostigmine, are available for the management of tropatepine poisoning. The aim of this study is to describe a series of tropatepine poisonings and to compare the management of patients. This epidemiological, retrospective, multicentre study reviewed tropatepine intoxications reported to French poison centres from 1 January 2000 to 13 July 2023. The relationship between reduction in central antimuscarinic signs and associated risk factors was assessed by univariate and multivariate logistic regression. A total of 458 cases of tropatepine poisoning were included. Peripheral and central antimuscarinic signs were observed in 214 (46.7%) and 102 patients (22.3%), respectively. For patients who ingested tropatepine alone (n = 94), 29 (30.8%) showed agitation or delirium. A reported median ingested dose of 270 mg of tropatepine was associated with the onset of central and peripheral antimuscarinic signs, compared with 100 mg for peripheral signs alone (P = 0.0012). The median (IQR) duration of central antimuscarinic signs was 24 h (12-48 h). Agitation was treated by neostigmine and physostigmine in 25 and 13 patients, respectively. In 16 (76%) patients treated with neostigmine, there was no improvement in central signs, whereas 13 (100%) patients responded favorably to physostigmine. After adjustment for ingested dose, the complete resolution of central antimuscarinic signs was significantly higher in patients treated with physostigmine than with neostigmine (odds ratio 6.61; 95% CI: 1.00-44.94]; P = 0.0499). Due to its long elimination half-life, tropatepine poisoning is frequently associated with a severe and prolonged antimuscarinic syndrome. Caring for these agitated patients requires substantial input from nursing staff. Physostigmine is still little used but appears to be effective in controlling the central antimuscarinic syndrome induced by tropatepine.
- 20 January 2026
- Published by Taylor & Francis in Clinical Toxicology
- p. 1-8
Tropatepine poisoning and management: a series of 458 cases
Tropatepine is an antiparkinsonian drug that can be associated with antimuscarinic delirium in overdose. Two acetylcholinesterase inhibitors, neostigmine and physostigmine, are available for the management of tropatepine poisoning. The aim of this study is to describe a series of tropatepine poisonings and to compare the management of patients. This epidemiological, retrospective, multicentre study reviewed tropatepine intoxications reported to French poison centres from 1 January 2000 to 13 July 2023. The relationship between reduction in central antimuscarinic signs and associated risk factors was assessed by univariate and multivariate logistic regression. A total of 458 cases of tropatepine poisoning were included. Peripheral and central antimuscarinic signs were observed in 214 (46.7%) and 102 patients (22.3%), respectively. For patients who ingested tropatepine alone (n = 94), 29 (30.8%) showed agitation or delirium. A reported median ingested dose of 270 mg of tropatepine was associated with the onset of central and peripheral antimuscarinic signs, compared with 100 mg for peripheral signs alone (P = 0.0012). The median (IQR) duration of central antimuscarinic signs was 24 h (12-48 h). Agitation was treated by neostigmine and physostigmine in 25 and 13 patients, respectively. In 16 (76%) patients treated with neostigmine, there was no improvement in central signs, whereas 13 (100%) patients responded favorably to physostigmine. After adjustment for ingested dose, the complete resolution of central antimuscarinic signs was significantly higher in patients treated with physostigmine than with neostigmine (odds ratio 6.61; 95% CI: 1.00-44.94]; P = 0.0499). Due to its long elimination half-life, tropatepine poisoning is frequently associated with a severe and prolonged antimuscarinic syndrome. Caring for these agitated patients requires substantial input from nursing staff. Physostigmine is still little used but appears to be effective in controlling the central antimuscarinic syndrome induced by tropatepine.
- 18 September 2025
- Published by Taylor & Francis in Clinical Toxicology
- Vol. 63 (11) , 952-958
Body packers and body stuffers: cocaine intoxications reported to French poison centers (January 1, 2020—December 31, 2024)
Cocaine use has increased significantly over the past three decades. This study aimed to analyze cases of cocaine intoxication involving body packing and body stuffing, focusing on symptomatology, treatment, and clinical outcomes. A retrospective analysis was performed of cases of cocaine poisoning recorded in the French national poison center database over a five-year period (2020-2024). Extracted data included demographics, amount and route of cocaine concealment, number of pellets, clinical presentation, management, outcomes, location of arrest, and packaging type. An ordinal logistic regression was conducted to identify factors associated with poisoning severity, using the Poisoning Severity Score as the dependent variable. Among 2,534 cases of cocaine intoxication, 146 involved body packers or body stuffers: 73 body packers and 73 body stuffers. The male-to-female ratio for body packers was 3.3:1, and for body stuffers, it was 72:1, with only one female. The median age of body packers was 25.5 years (range: 17-62 years) and for body stuffers, 28.2 years (range: 16-58 years). Body packers ingested between one and 190 pellets, while body stuffers ingested between one and ten pellets, each containing cocaine 1-15 g. Symptoms included gastrointestinal, cardiovascular, neurological, and respiratory effects. One death occurred among body packers, and two among body stuffers. Age was a significant predictor of severity, with older individuals at higher risk of severe outcomes. Cocaine intoxication in body packers and stuffers presents serious health risks. Body packers ingested larger quantities with more secure packaging, while body stuffers ingested smaller amounts but used less secure methods, often due to law enforcement urgency. Despite differences in ingestion patterns, both groups showed similar symptoms, with older body packers more likely to experience severe effects. While severe complications were rare, cocaine intoxication in both body packers and stuffers can be fatal, highlighting ongoing public health risks related to cocaine trafficking and the need for timely medical intervention.
- 18 September 2025
- Published by Taylor & Francis in Clinical Toxicology
- Vol. 63 (11) , 952-958
Body packers and body stuffers: cocaine intoxications reported to French poison centers (January 1, 2020—December 31, 2024)
Cocaine use has increased significantly over the past three decades. This study aimed to analyze cases of cocaine intoxication involving body packing and body stuffing, focusing on symptomatology, treatment, and clinical outcomes. A retrospective analysis was performed of cases of cocaine poisoning recorded in the French national poison center database over a five-year period (2020-2024). Extracted data included demographics, amount and route of cocaine concealment, number of pellets, clinical presentation, management, outcomes, location of arrest, and packaging type. An ordinal logistic regression was conducted to identify factors associated with poisoning severity, using the Poisoning Severity Score as the dependent variable. Among 2,534 cases of cocaine intoxication, 146 involved body packers or body stuffers: 73 body packers and 73 body stuffers. The male-to-female ratio for body packers was 3.3:1, and for body stuffers, it was 72:1, with only one female. The median age of body packers was 25.5 years (range: 17-62 years) and for body stuffers, 28.2 years (range: 16-58 years). Body packers ingested between one and 190 pellets, while body stuffers ingested between one and ten pellets, each containing cocaine 1-15 g. Symptoms included gastrointestinal, cardiovascular, neurological, and respiratory effects. One death occurred among body packers, and two among body stuffers. Age was a significant predictor of severity, with older individuals at higher risk of severe outcomes. Cocaine intoxication in body packers and stuffers presents serious health risks. Body packers ingested larger quantities with more secure packaging, while body stuffers ingested smaller amounts but used less secure methods, often due to law enforcement urgency. Despite differences in ingestion patterns, both groups showed similar symptoms, with older body packers more likely to experience severe effects. While severe complications were rare, cocaine intoxication in both body packers and stuffers can be fatal, highlighting ongoing public health risks related to cocaine trafficking and the need for timely medical intervention.
- 21 July 2025
- Published by Taylor & Francis in Clinical Toxicology
- Vol. 63 (8) , 579-587
Adverse reactions of liquorice consumed in the diet: a 10-year retrospective study of poison centres in France
We aimed to describe the symptoms, patient demographics, and trends over time of adverse effects related to liquorice consumed in the diet reported to French poison centres. We performed a retrospective study of data from French poison centres of cases of adverse effects of liquorice consumed in the diet, with a high causality score, between 2012 and 2021 (10 years). Sixty-four cases were included. The annual number of cases ranged from three to nine, with no significant variation over the study period. Liquorice-induced reactions were very rare (0.008% of all cases with symptoms reported to French poison centres). The products consumed were non-alcoholic beverages (non-alcoholic pastis, liquorice-based Antésite®, and liquorice syrup), alcoholic beverages of the pastis type (10.9%), confectionery containing liquorice (12.5%), confectionery made with liquorice extract only (9.4%), herbal teas (12.5%) and food supplements (4.7%). Consumption was commonly chronic (67.2%) and non-compliant (70.3%). Chronic users presented with symptoms suggestive of pseudohyperaldosteronism, the severity of which seemed to correlate with the amount of glycyrrhizin ingested. Severity was high in 43.8% of cases. When the outcome was known (56.3%), it was favourable in almost all cases (94.4%), often after inpatient care, particularly in an intensive care unit. One patient had sequelae due to a stroke, and one fatality was reported. Severe cases were observed with all types of products, except liquorice syrup and food supplements, and more frequently with beverages (pastis with or without alcohol, and Antésite®). Due to significant variability in response to glycyrrhizin, some patients presented signs and symptoms suggestive of pseudohyperaldosteronism such as hypokalaemia, salt and water retention, and hypertension despite consuming the product as directed. Liquorice-induced effects were rarely reported to French poison centres, but their severity was high. Most patients were adults with chronic and non-compliant consumption, especially of soft drinks, with a clinical presentation suggestive of pseudohyperaldosteronism.
- 21 July 2025
- Published by Taylor & Francis in Clinical Toxicology
- Vol. 63 (8) , 579-587
Adverse reactions of liquorice consumed in the diet: a 10-year retrospective study of poison centres in France
We aimed to describe the symptoms, patient demographics, and trends over time of adverse effects related to liquorice consumed in the diet reported to French poison centres. We performed a retrospective study of data from French poison centres of cases of adverse effects of liquorice consumed in the diet, with a high causality score, between 2012 and 2021 (10 years). Sixty-four cases were included. The annual number of cases ranged from three to nine, with no significant variation over the study period. Liquorice-induced reactions were very rare (0.008% of all cases with symptoms reported to French poison centres). The products consumed were non-alcoholic beverages (non-alcoholic pastis, liquorice-based Antésite®, and liquorice syrup), alcoholic beverages of the pastis type (10.9%), confectionery containing liquorice (12.5%), confectionery made with liquorice extract only (9.4%), herbal teas (12.5%) and food supplements (4.7%). Consumption was commonly chronic (67.2%) and non-compliant (70.3%). Chronic users presented with symptoms suggestive of pseudohyperaldosteronism, the severity of which seemed to correlate with the amount of glycyrrhizin ingested. Severity was high in 43.8% of cases. When the outcome was known (56.3%), it was favourable in almost all cases (94.4%), often after inpatient care, particularly in an intensive care unit. One patient had sequelae due to a stroke, and one fatality was reported. Severe cases were observed with all types of products, except liquorice syrup and food supplements, and more frequently with beverages (pastis with or without alcohol, and Antésite®). Due to significant variability in response to glycyrrhizin, some patients presented signs and symptoms suggestive of pseudohyperaldosteronism such as hypokalaemia, salt and water retention, and hypertension despite consuming the product as directed. Liquorice-induced effects were rarely reported to French poison centres, but their severity was high. Most patients were adults with chronic and non-compliant consumption, especially of soft drinks, with a clinical presentation suggestive of pseudohyperaldosteronism.
- 14 July 2025
- Published by Taylor & Francis in Clinical Toxicology
- Vol. 63 (8) , 570-578
Evaluation of the reproducibility and validity of the use of the causality assessment method for poisonings designed and applied by the French poison control centres
French poison control centres have developed and use a standardised causality assessment method based on a decision tree for poisoning cases involving a wide range of xenobiotics, which includes five ascending levels (I0-I4) and six determinants. This study was designed to evaluate inter-rater reliability and the validity of using this method. A reference group of toxicologists identified five categories of cases - based on the route of exposure with two circumstances for the oral route - recorded in the French National Database of Poisonings. The reference group assessed by consensus the level of causality of each randomly selected case as the reference level. Toxicologists from poison centres, not belonging to the reference group, were selected as raters. Inter-rater reliability was assessed using weighted Light's kappa. The results of raters were compared against the reference to test the validity of the method. A subgroup analysis of inter-rater reliability was also performed according to rater experience, case category, and causality determinant. Nineteen raters reviewed the 86 cases selected by the reference group. Kappa was equal to 0.55 (moderate agreement). Sensitivity was 0.90 and specificity was 0.62 when comparing I0 versus I1-I4 classes. The agreement between raters increased with experience except for the most experienced group. Ocular route of exposure had the highest kappa (0.70) among the five case categories. Kappa for the causality determinants varied from 0.31 (exposure) to 0.54 (bibliographical references). The causality assessment of poisonings was carried out on real-life cases. Our results are close to those of studies on causality methods in pharmacovigilance and nutrivigilance, despite a wider scope of application. Causality assessment method employed by French poison control centres is useful, although coding of some determinants should be improved. Further refinement of the causality assessment method will also further enhance its utility.
- 14 July 2025
- Published by Taylor & Francis in Clinical Toxicology
- Vol. 63 (8) , 570-578
Evaluation of the reproducibility and validity of the use of the causality assessment method for poisonings designed and applied by the French poison control centres
French poison control centres have developed and use a standardised causality assessment method based on a decision tree for poisoning cases involving a wide range of xenobiotics, which includes five ascending levels (I0-I4) and six determinants. This study was designed to evaluate inter-rater reliability and the validity of using this method. A reference group of toxicologists identified five categories of cases - based on the route of exposure with two circumstances for the oral route - recorded in the French National Database of Poisonings. The reference group assessed by consensus the level of causality of each randomly selected case as the reference level. Toxicologists from poison centres, not belonging to the reference group, were selected as raters. Inter-rater reliability was assessed using weighted Light's kappa. The results of raters were compared against the reference to test the validity of the method. A subgroup analysis of inter-rater reliability was also performed according to rater experience, case category, and causality determinant. Nineteen raters reviewed the 86 cases selected by the reference group. Kappa was equal to 0.55 (moderate agreement). Sensitivity was 0.90 and specificity was 0.62 when comparing I0 versus I1-I4 classes. The agreement between raters increased with experience except for the most experienced group. Ocular route of exposure had the highest kappa (0.70) among the five case categories. Kappa for the causality determinants varied from 0.31 (exposure) to 0.54 (bibliographical references). The causality assessment of poisonings was carried out on real-life cases. Our results are close to those of studies on causality methods in pharmacovigilance and nutrivigilance, despite a wider scope of application. Causality assessment method employed by French poison control centres is useful, although coding of some determinants should be improved. Further refinement of the causality assessment method will also further enhance its utility.
- Open Access
- 16 June 2025
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 352, 120161
Use and health effects of herbal medicine Ocotea guianensis during pregnancy in French Guiana
- 16 June 2025
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 352, 120161
Open AccessUse and health effects of herbal medicine Ocotea guianensis during pregnancy in French Guiana
- Open Access
Cross-Analytical Strategies to Tackle “Medicines in Disguise” Presented as Food Supplements, a New Threat for Human Health
Plant-based food supplements (FS) of doubtful traceability have now emerged as a new threat to human health. Food supplements adulterated with pharmaceutical ingredients are considered “medicines in disguise” by regulatory authorities, which is a sub-category of falsified medicines. In the context of illegal manufacture and trade, as well as in the absence of an official phyto- and/or pharmacovigilance system, emergency departments and poison control centers constitute a early warning system for detecting ingested suspect FS. In the present investigation, we set up efficient workflows for the systematic characterization of adulterated plant-based FS in the context of an original local early warning alert system (i.e., FalsiMedTrack) involving an emergency department, a poison center, and academic analytical chemistry laboratories. Fit-for-purpose cross-analytical methods were employed, including sophisticated methods such as liquid chromatography coupled to high-resolution mass spectrometry, nuclear magnetic resonance, X-ray powder diffraction, as well as the most accessible and affordable HPLC method with UV/DAD detection. The strategy was applied successfully to typical cases of suspect plant-based health products, i.e., sample incriminated in patients experiencing side effects and herbal products currently commercialized for their “amazing health benefits”. The samples contained active pharmaceutical ingredients, including diclofenac, piroxicam, dexamethasone 21-acetate, and sibutramine. We provided evidence of “medicines in disguise” presented as food supplements, which raises concerns about their quality and safety.
Open AccessCross-Analytical Strategies to Tackle “Medicines in Disguise” Presented as Food Supplements, a New Threat for Human Health
Plant-based food supplements (FS) of doubtful traceability have now emerged as a new threat to human health. Food supplements adulterated with pharmaceutical ingredients are considered “medicines in disguise” by regulatory authorities, which is a sub-category of falsified medicines. In the context of illegal manufacture and trade, as well as in the absence of an official phyto- and/or pharmacovigilance system, emergency departments and poison control centers constitute a early warning system for detecting ingested suspect FS. In the present investigation, we set up efficient workflows for the systematic characterization of adulterated plant-based FS in the context of an original local early warning alert system (i.e., FalsiMedTrack) involving an emergency department, a poison center, and academic analytical chemistry laboratories. Fit-for-purpose cross-analytical methods were employed, including sophisticated methods such as liquid chromatography coupled to high-resolution mass spectrometry, nuclear magnetic resonance, X-ray powder diffraction, as well as the most accessible and affordable HPLC method with UV/DAD detection. The strategy was applied successfully to typical cases of suspect plant-based health products, i.e., sample incriminated in patients experiencing side effects and herbal products currently commercialized for their “amazing health benefits”. The samples contained active pharmaceutical ingredients, including diclofenac, piroxicam, dexamethasone 21-acetate, and sibutramine. We provided evidence of “medicines in disguise” presented as food supplements, which raises concerns about their quality and safety.
- 9 December 2024
- Published by Taylor & Francis in Clinical Toxicology
- Vol. 63 (2) , 148-149
Forensic pre-hospital deaths related to pentobarbital in the Paris area
- 9 December 2024
- Published by Taylor & Francis in Clinical Toxicology
- Vol. 63 (2) , 148-149
Forensic pre-hospital deaths related to pentobarbital in the Paris area